Here is the latest shareholding Pattern of FERVENT SYNERGIES. For more details, see the FERVENT SYNERGIES financial fact sheet and FERVENT SYNERGIES share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 70.56 | 70.56 | 73.33 | 73.33 | 73.33 | 73.33 | 73.33 | 73.33 | |
Foreign Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Promoters | % | 70.56 | 70.56 | 73.33 | 73.33 | 73.33 | 73.33 | 73.33 | 73.33 | |
Mutual Funds | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Financial institution/Banks/Insurance | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Institution | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Bodies Corporate | % | 17.69 | 17.69 | 14.60 | 14.64 | 14.64 | 14.60 | 14.29 | 13.93 | |
Individuals | % | 11.60 | 11.55 | 11.87 | 11.79 | 11.83 | 11.87 | 12.16 | 12.51 | |
NRIs/OCBs | % | 0.02 | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 0.13 | 0.17 | 0.18 | 0.22 | 0.19 | 0.19 | 0.21 | 0.21 | |
Total Non-Institution | % | 29.44 | 29.44 | 26.67 | 26.67 | 26.67 | 26.67 | 26.67 | 26.67 | |
Total Public | % | 29.00 | 29.00 | 27.00 | 27.00 | 27.00 | 27.00 | 27.00 | 27.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Subscriber Feature |
More Trading Company Shareholding Pattern: CIPLA ZYDUS LIFESCIENCES DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB
Asian stocks fell on Friday, while the dollar advanced as strong US economic data bolstered the prospect of interest rates staying higher for longer.